The listed chemicals, while not directly activating SCP-2, are involved in various aspects of lipid metabolism and transport, processes in which SCP-2 plays a significant role. These compounds exert their influence through different mechanisms, impacting SCP-2 activity or expression indirectly. Forskolin and IBMX modulate cAMP levels, a second messenger involved in various cellular processes including lipid metabolism. By altering cAMP levels, these compounds can influence the pathways regulating lipid transport and metabolism, affecting SCP-2 function. GW501516 (Cardarine), Rosiglitazone, and Fenofibrate are agonists for PPAR (Peroxisome Proliferator-Activated Receptors) subtypes – δ, γ, and α, respectively. PPARs are nuclear hormone receptors that play crucial roles in regulating lipid metabolism. By activating these receptors, these compounds can modify the expression of genes involved in lipid transport and metabolism, influencing SCP-2 activity.
Omega-3 Fatty Acids and Nicotinic Acid (Niacin) are known to modulate lipid profiles and metabolism. Their effects on lipid pathways could have downstream impacts on SCP-2 function, given its role in lipid transport. Statins, like Simvastatin, and Ezetimibe alter cholesterol metabolism – statins by inhibiting cholesterol synthesis and Ezetimibe by inhibiting its intestinal absorption. These alterations in cholesterol homeostasis could indirectly influence SCP-2 activity. Cholic Acid and Ursodeoxycholic Acid, being primary and secondary bile acids, respectively, are directly involved in lipid digestion and absorption. Their roles in these processes could intersect with the function of SCP-2 in lipid transport. Lastly, Orlistat, a lipase inhibitor, reduces the absorption of fats from the diet. This reduction in fat absorption could indirectly affect the activity of SCP-2 in lipid transport within cells. In summary, these compounds represent a diverse array of agents involved in lipid metabolism and transport. Their indirect influence on SCP-2 activity highlights the complex and integrated nature of lipid homeostasis in the body, with SCP-2 playing a key role in these processes. Understanding how these agents affect lipid metabolism can provide insights into modulation of SCP-2's function in various physiological and pathological contexts.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, increasing cAMP levels, which can modulate lipid metabolism and potentially influence SCP-2 activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-specific inhibitor of phosphodiesterases, elevating cAMP and cGMP levels, which could affect lipid metabolism pathways involving SCP-2. | ||||||
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $82.00 $179.00 | 28 | |
A PPARδ agonist, known to influence lipid metabolism, potentially affecting pathways where SCP-2 is involved. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
A PPARγ agonist, used in regulating lipid metabolism, which could indirectly impact SCP-2 activity. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Activates PPARα, influencing lipid metabolism, and potentially affecting SCP-2 associated pathways. | ||||||
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $94.00 $210.00 $1779.00 $8021.00 $16657.00 | 11 | |
Known to influence lipid metabolism and could indirectly affect the function or regulation of SCP-2. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Inhibitors of HMG-CoA reductase, affecting cholesterol synthesis and potentially influencing SCP-2 activity in lipid metabolism. | ||||||
Cholic acid | 81-25-4 | sc-255020 sc-255020A sc-255020B sc-255020C sc-255020D | 25 g 100 g 500 g 1 kg 5 kg | $49.00 $123.00 $578.00 $1018.00 $4570.00 | 11 | |
A primary bile acid involved in lipid digestion and absorption, potentially influencing SCP-2 activity. | ||||||
Ursodeoxycholic acid | 128-13-2 | sc-204935 sc-204935A | 1 g 5 g | $52.00 $131.00 | 4 | |
A secondary bile acid used in the management of cholesterol gallstones, potentially impacting pathways involving SCP-2. | ||||||
Ezetimibe | 163222-33-1 | sc-205690 sc-205690A | 25 mg 100 mg | $96.00 $241.00 | 12 | |
Inhibits the intestinal absorption of cholesterol, potentially impacting lipid metabolism pathways where SCP-2 is involved. | ||||||